AlphaCrest Capital Management LLC - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 217 filers reported holding PTC THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.

Quarter-by-quarter ownership
AlphaCrest Capital Management LLC ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$222,000
-36.6%
4,416
-49.5%
0.01%
-17.6%
Q2 2022$350,000
-35.3%
8,743
-39.7%
0.02%
-43.3%
Q1 2022$541,000
-32.8%
14,490
-28.3%
0.03%0.0%
Q4 2021$805,000
-33.4%
20,222
-37.7%
0.03%
-51.6%
Q3 2021$1,208,000
+38.2%
32,476
+57.0%
0.06%
+63.2%
Q2 2021$874,000
+45.4%
20,686
+62.9%
0.04%
+15.2%
Q1 2021$601,000
+153.6%
12,697
+226.3%
0.03%
+65.0%
Q4 2020$237,000
-37.5%
3,891
-52.0%
0.02%
-51.2%
Q3 2020$379,000
+86.7%
8,104
+103.0%
0.04%
+20.6%
Q2 2020$203,000
-36.2%
3,993
-57.6%
0.03%
+78.9%
Q3 2019$318,0009,4100.02%
Other shareholders
PTC THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 7,235,196$162,140,7423.42%
Camber Capital Management LP 3,400,000$76,1942.51%
ARMISTICE CAPITAL, LLC 6,150,000$137,821,5002.11%
GREAT POINT PARTNERS LLC 500,000$11,205,0002.04%
COWEN AND COMPANY, LLC 799,511$17,917,0411.25%
GEORGE KAISER FAMILY FOUNDATION 45,816$6,491,2111.22%
SPHERA FUNDS MANAGEMENT LTD. 218,459$4,895,6660.89%
SECTORAL ASSET MANAGEMENT INC 187,016$4,191,0290.82%
Nebula Research & Development LLC 21,858$489,8380.26%
Phocas Financial Corp. 64,701$1,450,0000.21%
View complete list of PTC THERAPEUTICS INC shareholders